# Mark E. Robson

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-e-robson/

## Facts

| Field | Value |
| --- | --- |
| Citations | 59,983 |
| Field | BRCA gene mutations in cancer |
| h-index | 114 |
| i10-index | 398 |
| Last Known Institution | Memorial Sloan Kettering Cancer Center |
| OpenAlex ID | https://openalex.org/A5045514288 |
| ORCID iD | https://orcid.org/0000-0002-3109-1692 |
| Works | 945 |

## Researcher papers

Showing 12 of 14.

- [Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients](https://scholariq.org/papers/mutational-landscape-of-metastatic-cancer-revealed-from-prospective-clinical/)
- [Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer](https://scholariq.org/papers/inherited-dna-repair-gene-mutations-in-men-with-metastatic-prostate-cancer/)
- [ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer](https://scholariq.org/papers/esmo-clinical-practice-guideline-for-the-diagnosis-staging-and-treatment-of/)
- [Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group](https://scholariq.org/papers/recommendations-for-the-use-of-next-generation-sequencing-ngs-for-patients-with/)
- [The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers](https://scholariq.org/papers/the-genomic-landscape-of-endocrine-resistant-advanced-breast-cancers/)
- [Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes](https://scholariq.org/papers/therapy-related-clonal-hematopoiesis-in-patients-with-non-hematologic-cancers-is/)
- [High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants](https://scholariq.org/papers/high-intensity-sequencing-reveals-the-sources-of-plasma-circulating-cell-free/)
- [Cancer therapy shapes the fitness landscape of clonal hematopoiesis](https://scholariq.org/papers/cancer-therapy-shapes-the-fitness-landscape-of-clonal-hematopoiesis/)
- [Pathology of Breast and Ovarian Cancers among <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: Results from the Consortium of Investigators of Modifiers of <i>BRCA1</i> / <i>2</i> (CIMBA)](https://scholariq.org/papers/pathology-of-breast-and-ovarian-cancers-among-i-brca1-i-and-i-brca2-i-mutation/)
- [Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients](https://scholariq.org/papers/genomic-characterization-of-metastatic-patterns-from-prospective-clinical/)
- [Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing](https://scholariq.org/papers/mutation-detection-in-patients-with-advanced-cancer-by-universal-sequencing-of/)
- [Impairment of BRCA1-Related DNA Double-Strand Break Repair Leads to Ovarian Aging in Mice and Humans](https://scholariq.org/papers/impairment-of-brca1-related-dna-double-strand-break-repair-leads-to-ovarian/)

## Researcher topics

- [BRCA gene mutations in cancer](https://scholariq.org/topics/brca-gene-mutations-in-cancer/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Researcher university

- [Memorial Sloan Kettering Cancer Center](https://scholariq.org/institutions/memorial-sloan-kettering-cancer-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.